Efficacy of pregabalin in migraine prevention

Trial Profile

Efficacy of pregabalin in migraine prevention

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 11 May 2008

At a glance

  • Drugs Pregabalin (Primary) ; Valproate semisodium; Valproic acid
  • Indications Migraine
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2008 Status changed from initiated to withdrawn prior to recruitment, as reported by ClinicalTrials.gov.
    • 27 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top